A common maintenance treatment for inflammatory bowel conditions.
Reviewed by:
Dr. Steve Malen, PharmD
Dr. Steven Blikstein, PharmD
Strength
How would you like to get this medication?
Choose a strength and quantity to continue.
Mesalamine DR (Lialda) is a prescription medication used to maintain remission in ulcerative colitis, a chronic inflammatory bowel disease that affects the lining of the colon. It is designed for long-term use to help maintain symptom control in adults whose disease is already in remission. **Important: Regular kidney and liver monitoring is recommended to prevent rare but serious complications. Do not crush or chew capsules.**
Complete a health screening
A short questionnaire about your health history and current symptoms — takes about 2 minutes.
Provider reviews your answers
Provider review within 24 hours.
Prescription fulfilled
If approved, your Rx is sent to Invictus Pharmacy and you're notified by text or email. Free nationwide shipping.
Important safety information
Identifying contraindications helps prevent the use of Lialda in situations where it may cause harm. Recognizing these contraindications and taking necessary precautions are essential for patient safety.
By understanding these constraints, patients and healthcare providers can ensure that Lialda is used safely, avoiding potential complications associated with these risks.
Mesalamine DR refers to the delayed-release form of mesalamine. This formulation is crucial in ensuring that the drug reaches the specific areas of inflammation in the colon.
By bypassing the upper gastrointestinal tract and releasing the active ingredient in the colon, mesalamine DR effectively reduces inflammation associated with inflammatory bowel diseases such as ulcerative colitis. In doing so, it helps maintain remission and manage symptoms over the long term.
Note: This medication’s generic and brand-name formulations are used interchangeably throughout this article.
Lialda is a medication specifically designed to manage certain gastrointestinal conditions, particularly ulcerative colitis. As a brand-name drug, Lialda contains mesalamine, an anti-inflammatory agent that targets inflammation within the colon.
This medication is provided as a delayed-release capsule, ensuring the active ingredient is delivered directly to the site of inflammation in the lower gastrointestinal tract. This targeted approach maximizes the drug’s effectiveness in alleviating symptoms associated with ulcerative colitis.
⚠️ Important Safety Warning:
Mesalamine can cause kidney and liver toxicity in rare cases. Patients should undergo regular renal and hepatic function tests during treatment, especially if they have pre-existing kidney or liver disease or are taking nephrotoxic drugs.
Lialda is primarily used to manage conditions associated with inflammatory bowel disease, particularly ulcerative colitis. Its efficacy in reducing colon inflammation makes it a valuable tool in the therapeutic arsenal against these conditions.
Lialda’s role in preventing relapse and managing active symptoms makes it a cornerstone in the treatment of ulcerative colitis. The delayed-release formulation ensures that the active ingredient is delivered directly to the affected areas within the colon, enhancing its effectiveness and minimizing systemic side effects.
Lialda is formulated to deliver mesalamine directly to the colon, where it exerts its therapeutic effects by reducing inflammation. This targeted delivery is essential for the drug’s efficacy in treating inflammatory bowel diseases.
Lialda works by releasing mesalamine in the colon. The active ingredient acts as an anti-inflammatory agent by inhibiting the production of certain inflammatory chemicals, particularly prostaglandins and leukotrienes, within the colon’s lining.
This action reduces inflammation, thereby alleviating symptoms such as pain, diarrhea, and rectal bleeding associated with ulcerative colitis.
Lialda is designed as a delayed-release capsule to ensure that mesalamine is not released until it reaches the colon. The capsule’s coating dissolves at a specific pH level found in the intestines, allowing a gradual release of the active ingredient.
This design facilitates extended delivery and prolonged action, maximizing the drug’s therapeutic impact while minimizing systemic absorption and potential side effects.
This pharmacokinetic profile ensures that mesalamine remains in the colon long enough to be effective, reducing the frequency of administration and improving patient compliance. By delivering medication where it is needed most, Lialda offers a targeted approach to managing ulcerative colitis.
Proper dosing and administration of Lialda are vital to its effectiveness in managing ulcerative colitis. Understanding the recommended dosages and the correct way to take the medication ensures its optimal use.
The typical adult dosage for Lialda consists of four 0.375g capsules taken orally once daily in the morning. This dosage is established to maintain consistent levels of the medication in the colon, ensuring sustained anti-inflammatory effects throughout the day.
Maintaining the integrity of the capsules and adhering to the once-daily dosing schedule are key aspects of Lialda’s administration. These practices ensure the delayed-release mechanism functions correctly, enabling optimal therapeutic benefits in the management of ulcerative colitis.
While Lialda is generally well-tolerated, as with all medications, it can cause side effects. Understanding the potential common and serious side effects enables patients and healthcare providers to better manage treatment and ensure safety.
Being aware of these potential side effects and recognizing when to seek medical advice are crucial for safely managing treatment with Lialda. While serious side effects are rare, they require immediate attention to prevent complications.
Monitoring & Safety Considerations:
Understanding drug interactions is critical to ensuring the safe and effective use of Lialda. Interactions may alter how Lialda works or increase the risk of side effects.
Discussing all current medications, including over-the-counter drugs and supplements, with a healthcare provider is crucial to avoid adverse interactions and ensure optimal therapeutic effect. Proper management of drug interactions helps maintain the efficacy and safety of Lialda treatment.
Administration & Dosage
Lialda should be taken once daily, ideally in the morning. The capsule is designed to be swallowed whole to ensure proper release of the medication in the colon, maximizing its efficacy. Remember to take it consistently at the same time every day.
Lialda capsules should not be opened or crushed. They have a unique coating that allows for delayed release, ensuring the medication is properly delivered to the colon. Altering the capsule could impair this release mechanism, reducing the medication's effectiveness.
The typical dosage for adults is four 0.375g capsules taken once daily. Your healthcare provider might adjust this dose based on your specific medical requirements. Always adhere to your doctor’s instructions and never modify your dose without their guidance.
It's generally recommended to take Lialda in the morning. Taking it at the same time each day helps maintain consistent medication levels in your system, enhancing its effectiveness in managing ulcerative colitis symptoms.
Relief onset can vary among individuals, but many patients report noticing improvements in their gastrointestinal symptoms within several days of starting Lialda. Maintaining consistent use is essential for achieving optimal therapeutic benefits.
Uses & Mechanism of Action
Lialda is primarily used to maintain remission in patients with ulcerative colitis, a chronic inflammatory bowel disease. It helps reduce symptoms such as diarrhea and abdominal pain associated with this condition by targeting colon inflammation.
Lialda contains mesalamine, an anti-inflammatory agent that inhibits the production of substances in the colon that trigger inflammation and tissue damage. Doing so helps alleviate symptoms such as diarrhea and abdominal discomfort.
Lialda is not a steroid. It is categorized as an anti-inflammatory medication, specifically designed to treat gastrointestinal tract inflammation. This distinguishes it from corticosteroids, which have a broader immune-suppressing function.
Lialda does not function as an immunosuppressant. It targets inflammation locally within the colon without systematically suppressing the immune system, making it a safer option for long-term management of ulcerative colitis.
Mesalamine DR, or delayed-release mesalamine, is used to manage inflammation in the colon lining associated with ulcerative colitis and other inflammatory bowel diseases, offering targeted anti-inflammatory effects directly where needed.
Side Effects & Safety
Common side effects associated with Lialda include headache, nausea, diarrhea, and abdominal pain. If these symptoms persist or worsen over time, it is advisable to consult your healthcare provider for further evaluation and management.
Hair loss is not a commonly reported side effect of Lialda. Should you experience significant hair loss, it would be prudent to contact your doctor for an assessment, as it may be attributable to other health-related issues.
Weight gain is not typically associated with Lialda usage. Notable changes in weight might be more closely related to overall ulcerative colitis management or lifestyle factors than to a direct effect of the medication itself.
Serious side effects can include severe abdominal pain, exacerbation of ulcerative colitis symptoms, notable mood changes, and signs of kidney dysfunction. Should any of these occur, immediate consultation with your healthcare provider is essential.
The safety and efficacy of Lialda in children have not been conclusively established. Lialda should only be given to children under the guidance and prescription of a qualified pediatric gastroenterologist.
Interactions & Contraindications
Lialda might interact with other medications, including certain blood thinners and anti-inflammatory drugs. It is crucial to discuss your full list of medications and supplements with your healthcare provider to identify and prevent potential interactions.
Alcohol consumption is generally discouraged while taking Lialda, as it may exacerbate side effects or interfere with the drug's effectiveness. Discussing alcohol use with your healthcare provider can help tailor safe use recommendations.
Lialda should be used cautiously in individuals with existing kidney or liver issues. Your healthcare provider should thoroughly review your medical history to ensure Lialda is a safe option for your treatment plan.
The safety of Lialda during pregnancy has not been comprehensively established. Pregnant women should engage in detailed discussions with their healthcare providers to weigh potential benefits against any risks to the developing fetus.
While Lialda does not require food for effectiveness, taking mesalamine formulations like Lialda with food can aid absorption and reduce gastrointestinal discomfort, ensuring optimal therapeutic effect.
Generic & Alternatives
Mesalamine DR is a delayed-release form of mesalamine used in various formulations, like Lialda, to treat inflammatory bowel diseases. It delivers targeted colon-specific therapy, ensuring maximum anti-inflammatory impact where needed.
Generic versions of Lialda may be available depending on specific market regulations and production. Checking with pharmacies or your healthcare provider is the best way to get the most up-to-date information on the availability of generic alternatives.
The cost of Lialda can vary widely based on factors such as insurance coverage, pharmacy pricing, and whether a brand-name or generic version is purchased. Consulting a pharmacist can provide precise pricing details for your plan.
Coverage for mesalamine DR under Medicare can differ, with specifics regarding coverage and costs determined by individual Medicare Part D plans. Contacting your plan provider is necessary to verify exact coverage details and personal expenses.
Alternatives to Lialda may include other mesalamine products, such as Lialda and Asacol, or medications from other drug classes, such as corticosteroids and immunosuppressants. Healthcare providers can guide you to the most appropriate treatment option.